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Abstract
Background Few studies have recently showed functional
and morphological changes of the thyroid gland in relation
to obesity. To our knowledge, no data are available about
the prevalence of thyroid nodules in female obese patients.
The aim of this study was to investigate the prevalence of
thyroid nodules in morbidly obese women.
Methods One hundred eight consecutive female obese
patients were selected from those referred to our medical
and surgery outpatients providing that following criteria
were satisfied: (1) affected by morbid obesity (body mass
index (BMI) >40 kg/m2); (2) no previous diagnosis of
thyroid disease; (3) biochemically proven euthyroid state at
the time of recruitment. Ninety-seven control subjects,
constituted by normo-weight and/or slightly overweight
(BMI≤30 kg/m2) women, should satisfy the above criteria
2 and 3. All the subjects were submitted to ultrasound
investigation.
Results The two groups of patients displayed no differences
for age and fT4 levels. Obese patients clearly showed a
lower prevalence of thyroid nodules [odds ratio 0.294, 95%
confidence interval 0.206–0.382]. A single nodule was
found in 23% of obese patients as compared to 65% of
control subjects (p<0.0001). No difference for age (year)
was found between obese and non-obese subjects with
nodules (40.5±8.2 vs. 44.2±8.9, respectively, p=0.07).
Conclusions Our data clearly show a significantly lower
prevalence of thyroid nodules in morbidly obese patients.
Further studies are needed to confirm and to understand this
first observation.
Keywords Obesity . Thyroid nodule
Introduction
Obesity has become a worldwide health problem both in
developed and developing countries [1–5]. It has been
associated to the increasing incidence of many other
chronic diseases, such as diabetes mellitus, hypertension
and cardiovascular disease [6].
A potential role for obesity as factor in cancer
development, including thyroid cancer, has been reported
[7].
It is a common observation that a significant propor-
tion of patients with morbid obesity display slightly
increased serum thyroid-stimulating hormone (TSH)
levels. However, there is still considerable disagreement
as to the physiopathological mechanism responsible for
this phenomenon and the clinical significance of this
hyperthyrotropinemia [8].
Obesity is associated with structural changes of thyroid
morphology, as assessed by ultrasound, which seems to be
not related to thyroid autoimmunity both in children than in
adults [9, 10].
Moreover, previous studies have shown a correlation
between thyroid volume and body mass index (BMI),
mainly in obese women [11–14].
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To our knowledge, no data are available about the
prevalence of thyroid nodules in obese women. Therefore,
in this study, we investigated the prevalence of thyroid
nodules in morbidly obese subjects.
Methods and Procedures
From May 2009 to June 2010, 108 consecutive female
obese patients were selected from those referred to our
medical and surgery outpatient clinics. Patients were
enrolled in the study provided that following criteria
were satisfied: (1) affected by morbid obesity (BMI>
40 kg/m2); (2) no previous diagnosis of thyroid disease;
(3) biochemically proven euthyroid state at the time of
recruitment.
Ninety-seven controls were selected among patients
referred to our division during the campaign for the
prevention of thyroid disease (Settimana Nazionale della
Tiroide) led by the Associazione Italiana della Tiroide, from
15th to 19th March, 2010.
Control subjects, constituted by normo-weight and/or
slightly overweight (BMI≤30 kg/m2) women, should
satisfy the above criteria 2 and 3. BMI was calculated as
the weight (kg) measured to the nearest kilogram divided
by the square of height determined to the nearest
centimetre (m).
All the subjects in the present study were Caucasian,
born and living in the greater Brescia area, an endemic zone
for goitre [15].
Written informed consent was obtained from all subjects.
Ultrasound
All the subjects were submitted to ultrasound investiga-
tion, which was conducted according to a standard
procedure by the same skilled sonographer. Ultrasound
investigations were performed using an ultrasonographic
scanner (LOGIQ 9, General Electric, Milwaukee, WI,
USA) equipped with a 10–14 MHz linear transducer for
morphological study. Totally, echo-free nodules were
assumed to be cystic nodules and were not considered
in this study. The volumes of thyroid glands and thyroid
nodules were calculated with the standard formula for an
ellipsoid volume.
Serum Assay
Serum fT4 (normal range: 7.0–18.0 pg/mL) and serum TSH
(normal range 0.270–4.200 mU/L) were determined by
microparticle chemiluminescence enzyme immunoassays
from Abbott Laboratories (Architect i2000 System®,
Abbott Park, IL, USA).
Statistical Analysis
Statistical analysis was performed using the SPSS software
version 17 (SPSS, Inc., Chicago, IL, USA).
To compare the case and control groups, the χ2 test was
used for categorical variables and an analysis of variance or
the Mann–Whitney U test for quantitative variables, as
appropriate. A logistic analysis was performed to examine
the influence of confounders (age, risk factors) on the
prevalence of thyroid nodules.
A p value <0.05 was considered statistically significant.
Results
From May 2009 to June 2010, we recruited 108 patients
affected by morbid obesity and 97 control subjects satisfying
the assigned criteria for ‘cases’ and ‘controls’, respectively.
The clinical and biochemical data of the subjects
enrolled in the study subdivided according to their body
weight phenotype are reported in Table 1.
The two groups of patients displayed no differences for
age and fT4 levels. The obese women showed a significant
higher serum TSH levels (mU/L) than control group (3.4±
1.2 vs. 2.1±1.7, p<0.0001).
Among factors potentially associated with the develop-
ment of thyroid nodules, a positive family history of thyroid
disease, defined as the generic occurrence, reported by the
subject, of ‘thyroid disorders’ (not specifically thyroid
nodules), was slightly, but not significantly, more frequent
in the obese group; smoking and radiation exposure were
super-imposable among groups.
At ultrasound evaluation, thyroid gland showed a
hypoechoic feature more frequent in obese than in non-
obese subjects (76.4% vs. 15.7%, respectively, p<0.0001).
Table 1 Clinical and biochemical data of the subjects enrolled in the
study
Morbidly obese
patients
Controls P value
Number of cases 108 97
Age (years) 40.2±7.0 41.4±11.2 NS
BMI (Kg/m2) 44.6±2.8 27.0±2.4 <0.0001
Smokers (%) 9.1 10.5 NS
Family history of thyroid
disease (%)
11.4 8.2 NS
Radiation exposure (%) 0 0.9 NS
TSH (mU/L) 3.3±1.2 2.1±1.6 <0.0001
fT4 (pg/mL) 14.2±4.1 14.6±4.2 NS
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The prevalence and size of thyroid nodules, as well as,
the thyroid size in the two groups are reported in Table 2,
whereas the ultrasound characteristics of thyroid nodules
are reported in Table 3.
Obese patients clearly showed a lower prevalence of
thyroid nodules [odds ratio 0.294, 95% confidence interval
0.206–0.382], but with a significant larger volume (ml) of
lesions, as compared to the control group (0.9±1.6 vs. 0.4±
0.4, p=0.004). No difference for age (year) was found
between obese and non-obese subjects with nodules (40.5±
8.2 vs. 44.2±8.9, respectively, p=0.07).
A single nodule was found in 23% of obese patients as
compared to 65% of control subjects, demonstrating a
statistical difference between the two groups (p<0.0001).
Nodules showed similar ultrasound characteristics (in
terms of echogenecity, margins, calcification, and vascularity)
between the two groups of subjects.
Thyroid volume was significantly larger in the obese
group than in control one, even after adjustment by
individual BMI and TSH values (20.1±5.0 vs. 18.2±5.5,
respectively, p=0.005).
Nodule(s) volume remained larger in these obese women
even after correction by the respective thyroid volume.
Discussion
The results of our study show that morbidly obese women
have significantly lower prevalence and lower number of
solid thyroid nodules.
Overall, there was a marked tendency for thyroid gland
to develop nodular lesions; namely, in cases of areas of
endemic goitre, from which both obese and controls
women of the present study were selected. Therefore, the
very high prevalence of thyroid nodules in the controls
group is not surprising and in agreement with findings
reported by ultrasound investigation performed in popula-
tion with similar characteristics [16, 17] and with our
previous report [18].
Few studies have investigated functional and morpho-
logical changes of the thyroid gland in relation to
obesity and/or metabolic syndrome [16, 19–23]. In
agreement with literature data, we showed a significant
higher serum TSH levels in obese patients compared to
control group. There is still considerable disagreement as
to the physiopathological mechanism responsible for this
phenomenon.
Some authors have suggested that hormonal media-
tors from adipose tissue could stimulate the hypothal-
amous–pituitary–thyroid axis in order to increase TSH
secretion [19, 24]; the main suspected is leptin, which
seems to up-regulate TRH expression [25], but the
clinical significance of this hyperthyrotropinemia is still
a matter of discussion [8].
Structural changes of thyroid morphology not related
to thyroid autoimmunity have recently been described in
morbid obesity. Our data confirm a recent study obtained
in children, which showed hypoechoic thyroid structure
more frequent in obese patients than those observed in
normo-weight and/or slightly overweight subjects [9].
More recently, we evidenced the same ultrasound feature
in adults [10].
To our knowledge, there are no explanations to this
observation. A hypothesis could be that patients with an
extreme weight excess may have the tendency to accumu-
late fat in the thyroid. However, Radetti et al. evidenced
only colloid drops and thyrocytes and not adipose cells in
thyroid cytological samples [9], making unlikely the
previous assumption.
Another intriguing hypothesis could be that the excess of
subcutaneous fat layer in the neck may interfere with the
normal acoustic impedance on ultrasound examination,
causing a reduction of frequency acoustic waves to be
reflected back to the probe. Nevertheless, we did not see
any correlation between thyroid ultrasound echogenicity
and subcutaneous fat thickness (data not shown). A positive
correlation between thyroid volume and body weight or
BMI has been observed [11–14, 16], but, to our knowledge,
Table 2 Thyroid size, prevalence, and size of thyroid
nodules
Morbidly obese
patients
Controls P value
Thyroid volume (ml) 20.1±5.0 18.2±5.5 0.005
Prevalence of nodules
(%)
27.8 71.1 <0.0001
Multiple nodules (%) 4.6 6.2 NS
Nodules per subjects 0.3±0.5 0.8±0.7 <0.0001
Nodule Volume (ml) 0.9±1.2 0.4±0.5 0.005
Nodule volume/Thyroid
volume (%)
3.7±4.6 1.8±2.4 0.005
Nodule size range (mm) 0.4–3.1 0.3–1.9 NA
Table 3 Ultrasound findings in thyroid nodules
US features Nodules in morbidly
obese patients (%)
Nodules in
controls (%)
P
value
Hyperchoic 5/35 (15.7) 11/81 (13.6) NS
Isoechoic 11/35 (30.1) 21/81 (25.9) NS
Hypoechoic 19/35 (55.2) 43/81 (53.1) NS
Calcification present 10/35 (28.7) 22/81 (27.2) NS
Blurred Margins 6/35 (17.7) 11/81 (13.6) NS
Intranodular vascularity 16/35 (45.6) 35/81 (43.2) NS
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no previous studies have investigated the prevalence of
thyroid nodules in morbidly obese women.
We clearly show a significantly lower prevalence and
lower number of solid thyroid nodules in these patients
than those observed in normo-weight and/or slightly
overweight subjects. However, the great difference of
thyroid nodules between the two groups of women is
considerable and raises the crucial issue of the possible
presence of bias or confounders. We reasonably excluded
the possibility that characteristics such as age and other
risk factors, known to be associated with thyroid
nodules, may have influenced our results. Although we
have no data on iodine excretion in the two groups, it is
highly unlikely that this could be significantly different
among them because all subjects in both groups were
born and were still living in the same mild iodine
deficiency area and had similar dietary behaviour.
Moreover, our results would seem to be opposite to
what would have been expected, basing upon reports
showing greater thyroid nodule prevalence in association
with the metabolic syndrome and insulin resistance.
However, it is fairly well established that the incidence
of insulin resistance and the metabolic syndrome, in
general, is greater among individuals with morbid obesity
than for their non-obese counterparts [11–16]. Unfortu-
nately, we have no data about insulin serum levels in our
morbidly obese patients. Anyway, clinical and genetic
evidence supports the concept that obesity does not
represent a continuous entity and that obese patients with
BMI lower or higher than 40 Kg/m2 are likely to harbour a
different disease [26]. For this reason, obese and morbidly
obese patients could show different thyroid phenotypes,
even if at this time we have not proven any argument to
explain our results.
A potential role, for obesity as factor in cancer
development including thyroid cancer, has been reported
[7]. A recent study by Boru et al. clearly showed a
significant association between morbidly obese women
attending bariatric surgery and malignancy, in particular
thyroid cancer [27]. The cytological or histological ascer-
tainment of thyroid nodules was not considered in the
protocol of this study and only few subjects were submitted
to fine needle aspiration cytology of their nodules.
Therefore, no data are available concerning the possible
occurrence of neoplastic lesions.
In conclusion, our data clearly show a significantly
lower prevalence of thyroid nodules in morbidly obese
women. Further studies are needed to confirm and to
understand this first observation.
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